Ultragenyx Pharmaceutical
RARE
RARE
151 hedge funds and large institutions have $3.33B invested in Ultragenyx Pharmaceutical in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 13 closing their positions.
Holders
151
Holders Change
+25
Holders Change %
+19.84%
% of All Funds
4.07%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
38
Increased
57
Reduced
40
Closed
13
Calls
$6.53M
Puts
$11.9M
Net Calls
-$5.33M
Net Calls Change
-$6.23M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MCM
151
Moore Capital Management
New York
| – | -$2.17M | -35,000 | Closed |
|
|
HCM
152
Highbridge Capital Management
New York
| – | -$2.13M | -34,311 | Closed |
|
|
CCI
153
Columbus Circle Investors
| – | -$1.33M | -21,428 | Closed |
|
|
UOC
154
UBS O'Connor
Chicago,
Illinois
| – | -$1.24M | -20,000 | Closed |
|
|
CSS
155
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$919K | -14,808 | Closed |
|
|
TI
156
Turner Investments
Berwyn,
Pennsylvania
| – | -$621K | -10,000 | Closed |
|
|
NCCM
157
Nine Chapters Capital Management
Short Hills,
New Jersey
| – | -$522K | -8,400 | Closed |
|
|
CI
158
Cowen Inc
New York
| – | -$251K | -4,050 | Closed |
|
|
DT
159
Diversified Trust
Memphis,
Tennessee
| – | -$213K | -3,430 | Closed |
|
|
BBHC
160
Brown Brothers Harriman & Co
New York
| – | -$33K | -525 | Closed |
|
|
PAM
161
Panagora Asset Management
Boston,
Massachusetts
| – | -$31K | -496 | Closed |
|
|
QT
162
Quantbot Technologies
New York
| – | -$29K | -472 | Closed |
|
163
Creative Planning
Overland Park,
Kansas
| – | -$8K | -121 | Closed |
|